PKD-IN-1

PKD-IN-1 (compound 32), an aminoethylamino-aryl (AEAA) compound, acts as PKD-1 inhibitor. PKD-IN-1 can be used for protein kinase D (PKD) -mediated diseases research[1].

Product Specifications

CAS Number

[956121-30-5]

UNSPSC

12352005

Hazard Statement

H302-H315-H319

Target

PKD

Type

Reference compound

Related Pathways

Apoptosis

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Cancer; Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/pkd-in-1.html

Solubility

10 mM in DMSO

Smiles

OC1=CC=C(Cl)C=C1C2=NC(NC[C@H](N)CC)=C3C=CC=CC3=N2

Molecular Formula

C18H19ClN4O

Molecular Weight

342.82

Precautions

P264-P270-P280-P302+P352-P305+P351+P338-P330-P362+P364-P501

References & Citations

[1]RT Michael, et al. Aminoethylamino-aryl (AEAA) compounds as PKD inhibitors and their preparation, pharmaceutical compositions and use in the treatment of PKD-mediated diseases: World Intellectual Property Organization, WO2007125331. 2007-11-08.